We are testing a new CAR-T cell treatment for patients with B-cell non-Hodgkin lymphomas. The goal is to see how safe and well-tolerated this therapy is.
Health conditions and diseases that the clinical trial is designed to study and treat.
Non-Hodgkin Lymphoma (NHL) is a type of cancer that originates in the lymphatic system, specifically affecting B-cells. It includes various subtypes, such as Diffuse Large B-cell Lymphoma (DLBCL) and aggressive forms of B-cell lymphoma, leading to symptoms like swollen lymph nodes, fever, weight loss, and night sweats.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.